LGC and Pharmidex form strategic alliance
Factors related to DMPK - the science of how molecules are broken down by the body and how long they stay in the bloodstream - are the major contributors to compound attrition. For this reason a reliable DMPK profile of compounds early in the drug discovery cycle is essential - it has the potential to save time, eliminate waste and thus add value to the drug discovery process.
By bringing together the world class bioanalytical capabilities of LGC with the pharmacology and drug discovery expertise of Pharmidex, the alliance will deliver a breadth and depth of DMPK service which will be hard to match. The partnership provides drug discovery companies with a very comprehensive offering - in silico, in vitro and beyond - across the whole drug discovery value chain, and is backed by a level of knowledge that is not commonly available in service companies.
Other news from the department business & finance
These products might interest you
Milli-Q® Services / MyMilli-Q™ by Merck Life Science
Services & Support for Water Purification Systems
Quality Care, Delivered. In Person & Online
Good Weighing Practice by Mettler-Toledo
Your Concrete Weighing Quality Assurance Plan
GWP Verification service
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.